NCT07544264

Brief Summary

Total knee arthroplasty (TKA) is one of the most successful procedures in orthopedic surgery for treating advanced knee osteoarthritis, providing pain relief, functional recovery, and improved quality of life. Advances in implant design and materials have further enhanced joint kinematics and patient satisfaction. An aging population has increased the number of elderly patients with comorbidities, potentially affecting surgical outcomes and implant longevity. Polyethylene has long been used in knee prostheses; early all-polyethylene tibial components were abandoned due to high wear and failure rates, in favor of metal-backed designs, which became the gold standard. Recently, highly cross-linked ultra-high-molecular-weight polyethylene (UHMWPE) has renewed interest in all-polyethylene tibial components, although their use remains limited. These implants offer potential advantages, including elimination of locking mechanism failures, reduced backside wear, lower costs, and possibly better load distribution. Evidence from registries, systematic reviews, and meta-analyses shows that 15-year survival of all-polyethylene tibial components is comparable or even superior to metal-backed designs, with no significant differences in clinical-functional outcomes. Additionally, all-poly components are significantly less expensive. Given these findings, increasing their use and evaluating outcomes in Italy is warranted. The aim of the present study is to assess implant survival of the Link Symphoknee prosthesis with an all-polyethylene tibial component, along with clinical-functional outcomes and post-discharge readmission rates in patients treated at the Rizzoli Orthopaedic Institute.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
78mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2032

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

6.4 years

First QC Date

April 15, 2026

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Implant failure

    It is defined as revision of the prosthesis for any reason-septic, aseptic, or traumatic.

    Up to 5 years post-surgery

Secondary Outcomes (5)

  • Knee injury and Osteoarthritis Outcome Score (KOOS)

    Up to 5 years post-surgery

  • Forgotten Joint Score (FJS)

    Up to 5 years post-surgery

  • Visual Analog Scale (VAS) pain

    Up to 5 years post-surgery

  • VAS Satisfaction

    Up to 5 years post-surgery

  • Hip-Knee-Ankle angle (HKA)

    Up to 5 years post-surgery

Study Arms (1)

TKA

EXPERIMENTAL

Implantation of the Link Symphoknee prosthesis with an all-polyethylene tibial component.

Device: Total knee arthroplasty

Interventions

Implantation of the Link Symphoknee prosthesis with an all-polyethylene tibial component

TKA

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects aged ≥50 and ≤85 years who are candidates for primary cemented total knee arthroplasty based on physical examination and medical history, including a diagnosis of severe knee pain and disability due to at least one of the following conditions:
  • Primary or secondary osteoarthritis
  • Collagen disorders and/or avascular necrosis of the femoral condyle
  • Moderate valgus, varus, or flexion deformities (Hip-Knee-Ankle angle within ±15°).
  • Patients who provide consent and are able to complete the scheduled study procedures and follow-up assessments.
  • Patients who sign the informed consent approved by the Ethics Committee.

You may not qualify if:

  • Patients under 50 years of age and over 85 years of age;
  • Diagnosis of rheumatoid arthritis;
  • Patients with a contralateral joint prosthesis on the same side;
  • Coronal plane deformity with a Hip-Knee-Ankle (HKA) angle greater than 15 degrees in varus or valgus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Rizzoli Orthopedic Institute

Bologna, 40136, Italy

Location

MeSH Terms

Conditions

Prosthesis Failure

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Central Study Contacts

stefano zaffagnini

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor Medicine and Surgery, University of Bologna

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 22, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

October 1, 2032

Study Completion (Estimated)

October 1, 2032

Last Updated

April 22, 2026

Record last verified: 2026-04

Locations